{"id":2364,"date":"2019-10-05T20:19:55","date_gmt":"2019-10-05T18:19:55","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2364"},"modified":"2024-06-19T14:38:10","modified_gmt":"2024-06-19T12:38:10","slug":"transformation-and-metastasis-2","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/transformation-and-metastasis-2\/","title":{"rendered":"Transformation and Metastasis"},"content":{"rendered":"\n

\n\t\tTransformation and metastasis\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

This group’s research aims to identify new therapeutic targets for cancer which can be directly translated into effective prevention or treatment strategies. Its aim is to understand the signalling pathways involved in the epithelial stem cell fate and homeostasis, their alterations during cancer and metastasis, and the interactions between tumour cells and their microenvironment.<\/p>\n

The experience of the group’s members includes mammary-gland development, breast cancer and immunology.<\/p>\n

\u00a0The group has a multidisciplinary focus and uses genetically modified mice models, patient-derived xenografts, clinical samples, organoids and 3D cultures, and molecular and cellular biology techniques to translate basic research into relevant clinical results.<\/p>\n

 <\/p>\n

147<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"608_gonzalez2\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t\u2022 To identify new therapeutic strategies and mechanisms of resistance to current treatments for breast cancer
\n\u2022 To evaluate the role of the RANK signalling pathway in epithelial homeostasis, inflammation and cancer, and its potential as a therapeutic target.\n\t\t\t\t\t
Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t